靜脈支架市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033）

慢性靜脈疾病（CVD）或慢性靜脈功能不全（CVI）正成為發展中國家和已開發國家的全球負擔。這是指下肢的靜脈壁和瓣膜無法有效發揮作用，導致血液越來越難以從下肢返回心臟的情況。

深部靜脈血栓 (DVT) 是一種可能危及生命的疾病，患者體內大的深層靜脈會形成血塊。大多數 DVT 發生在骨盆區域，髂股靜脈的近端或遠端。DVT 也可能發生在身體的其他部位。深部靜脈血栓（DVT）分為急性/亞急性和慢性。如果有明顯的狹窄或外在壓迫，可以考慮放置靜脈支架。

該報告深入探討了全球靜脈支架市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

目前市售靜脈支架及競爭狀況

• 洞察關鍵產業趨勢
• 2015年至2033年靜脈支架各細分市場總收入及市場前景
• 按部門劃分的程序總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家見解

• 靜脈支架市場的SWOT分析
• 靜脈支架市場競爭動態洞察與趨勢
• 按國家/地區劃分的醫療保健系統概覽
• 各國報銷政策
• 各國醫療技術法規現狀

Abstract

Venous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Venous Stents market for the year 2020 and beyond. Chronic Venous Disease (CVD) or Chronic venous insufficiency (CVI) has emerged as a global burden on developing and developed countries. It refers to the condition where venous walls and/or valves in the leg are not working efficiently and becomes increasingly difficult for blood to return to the heart from the legs.

Deep Vein Thrombosis (DVT) is a potential life threating condition where a blood clot is formed in the large deep veins in the body. Most of the DVT occurs proximal or distal to iliofemoral vein as well as in the pelvic area. They also can occur in other parts of the body. Deep Vein Thrombosis (DVT) can be characterized into acute/subacute and chronic. Venous stent placement is considered in case of significant stenosis or extrinsic compression.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Venous Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Venous Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Venous Stents market.
• Competitive dynamics insights and trends provided Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, Cook Group Inc, Medtronic Plc, OptiMed Medizinische Instrumente GmbH, Plus Medica GmbH.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Venous Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Venous Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Venous Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Venous Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Venous Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable